← brief for 2026-08-26 · Slowing decline

Is this the end of the beta-blocker debate in hemodialysis? — NephJC

Page No results yet Not peer reviewed

Key takeaways

This is a journal club discussion, not a new study. Doctors are arguing about beta blockers, a common blood pressure and heart drug, for people on dialysis. Two things drive the choice: whether the drug targets the heart specifically, and whether dialysis washes it out of the blood. The piece reviews older conflicting studies and reports no new results of its own.

Source

Page · Forager · 2026-08-21
https://www.nephjc.com/news/targetrial-betablokers